FFA
NYMX

Founders Financial Alliance’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Founders Financial Alliance’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-500
Closed -$1K – 1332
2020
Q3 		$1K Buy
+500
New +$1.46K ﹤0.01% 1341

Other funds holding NYMX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Founders Financial Alliance's NYMX Position: Q4 2020 in Review

Founders Financial Alliance sold out of Nymox Pharmaceutical Corp (NYMX) in Q4 2020, closing a stake of 500 shares — an estimated $1K sold.

Founders Financial Alliance first reported a position in NYMX in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 58 funds tracked by Wall St. Rank hold NYMX as of Q4 2020.

  • Founders Financial Alliance reported no remaining Nymox Pharmaceutical Corp position as of Q4 2020 after selling out during the quarter.
  • Founders Financial Alliance sold 500 Nymox Pharmaceutical Corp shares in Q4 2020, an estimated $1K.
  • Founders Financial Alliance first reported a position in Nymox Pharmaceutical Corp in Q3 2020 and held it in 1 quarter.
  • Founders Financial Alliance's Nymox Pharmaceutical Corp position peaked at $1K in Q3 2020.
  • 58 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q4 2020.

Based on Founders Financial Alliance's 13F filing for Q4 2020, filed 4 Feb 2021.